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After acute kidney injury (AKI), surviving cells within
the nephron proliferate and repair. We identify Sox9
as an acute epithelial stress response in renal regen-
eration. Translational profiling after AKI revealed a
rapid upregulation of Sox9 within proximal tubule
(PT) cells, the nephron cell type most vulnerable to
AKI. Descendants of Sox9+ cells generate the bulk
of the nephron during development and regenerate
functional PT epithelium after AKI-induced reactiva-
tion of Sox9 after renal injury. After restoration of
renal function post-AKI, persistent Sox9 expression
highlights regions of unresolved damage within
injured nephrons. Inactivation of Sox9 in PT cells
pre-injury indicates that Sox9 is required for the
normal course of post-AKI recovery. These findings
link Sox9 to cell intrinsic mechanisms regulating
development and repair of the mammalian nephron.INTRODUCTION
The clinical syndrome of acute kidney injury (AKI) is character-
ized by an abrupt decline in kidney function, leading to the accu-
mulation of toxic waste products of cellular metabolism and
derangement of electrolyte balance. AKI is frequently initiated
by ischemia reperfusion injury (IRI), as might occur on organ
transplant, and a variety of other insults such as sepsis, nephro-
toxic agents, and blockage of urinary flow (Abuelo, 2007). Prox-
imal tubular epithelial cells (PTECs) within the nephron exhibit
high metabolic activity and are the most vulnerable cell type
to these varied insults in most mammalian species, though
distal tubular epithelial cells are also affected in man (Oberbauer
et al., 1999; Bonventre and Yang, 2011). Despite advances in
medical care, AKI is associated with a significant increase in
morbidity and mortality, with in-hospital mortality rates ap-
proaching 50%–70% (Chertow et al., 2005). Moreover, survivors
of an episode of AKI show an enhanced risk of long-term pro-Cellgression to chronic kidney disease (CKD) and ultimately end-
state renal disease (ESRD; Coca et al., 2012).
In AKI, damage-invoking responses trigger necrotic and/or
apoptotic cell death depending upon the severity of injury and
initiate endogenous tubular repair. This process restores tubular
epithelial integrity, proximal tubule activity, and kidney function
over several days (Bonventre and Yang, 2011). Genetic fate-
mapping studies in the mouse suggest that intrinsic, surviving
tubular epithelial cells proliferate and repair damaged nephrons
(Humphreys et al., 2008). Whether all surviving epithelial cells
have similar replicative/repair capability or a distinct subset of
surviving epithelial cells effect repair on injury is not clear (Berger
andMoeller, 2014; Kumar et al., 2014; Smeets et al., 2013).While
there is good evidence from genetic cell labeling studies of termi-
nally differentiated cell types for the former mechanism (Kusaba
et al., 2014), other studies have argued for rare reparative stem/
progenitor cell types in the mouse and human kidney (Lazzeri
et al., 2007; Lindgren et al., 2011; Rinkevich et al., 2014; Romag-
nani, 2011). Importantly, the molecular drivers of the intrinsic
PTEC proliferative/repair responses post-injury have not been
identified. Further, the elevated risk of CKD points to potential
limitations in the normal repair processes (Chawla et al., 2014;
Kumar et al., 2014). Identifying the kidney’s intrinsic mechanisms
of repair is critical for developing novel regenerative strategies to
treat renal injury.
Recently, our laboratory applied translating ribosome affinity
purification (TRAP) methodology within an IRI-induced AKI
model to determine the translatome of distinct cell lineages
after renal injury in the mouse (Liu et al., 2014)). These studies
identified activation of Sox9, a member of the Sry-related high-
mobility group box of transcription factors (Wright et al., 1993),
as an early injury response signature within the nephron
population.
Sox9 plays a pivotal role in development of a number of cell
types and organ systems; for example, Sox9 activity is essential
for male sex determination and mammalian skeletal develop-
ment (Wagner et al., 1994). In the kidney, Sox9 and the closely
related family member Sox8 have redundant activities in the con-
trol of branching morphogenesis in the arborizing network of the
urinary transport system (Reginensi et al., 2011). Sox9 is alsoReports 12, 1325–1338, August 25, 2015 ª2015 The Authors 1325
Figure 1. Sox9 Is Upregulated in the Prox-
imal Tubules Early after Acute Kidney Injury
(A) TRAP microarray analysis of Sox9 levels in
Six2-Tet-GFP-Cre;Rosa26-EGFP-L10a-labeled
nephrons 4 and 24 hr after renal ischemia re-
perfusion injury (IRI). Mean ± SEM (NS, non-sig-
nificant; **p < 0.01, n = 3 mice/group).
(B) RNA sequencing (RNA-seq)-based temporal
comparative profile of Sox9, Havcr1, and Lcn2
transcript levels at varying times post-IRI (data
minimum three mice per group). Serum creatinine
levels at corresponding time points are displayed
(mean ± SEM; n = 6–8 mice/group).
(C) Fluidigm qPCR temporal analysis of Sox9,
Havcr1, and Lcn2 levels in response to renal IRI
and unilateral ureteral obstruction (UUO).
(D and E) Immunoanalysis for SOX9, LTL (lotus
tetragonolobus lectin, proximal tubule) and cal-
bindin (Calbindin-D28K, distal convoluted tubule)
in the 10-week adult C57BL6 kidney. DAPI de-
marcates nuclei. Arrows highlight SOX9+ cells.
Data are a minimum of three mice/group. Scale
bar, 100 mm. See also Figure S1.expressed within nephron precursors though the relationship of
Sox9+ cells to future nephron structures and the potential actions
of Sox9 in early nephrogenesis remain to be determined (Regi-
nensi et al., 2011), The association of renal phenotypes as one
component of the complex outcomes after loss of function of a
singleSOX9 allele inman is consistent with a conserved renal ac-
tion for SOX9 in human kidney development (Foster et al., 1994;
Wagner et al., 1994).
Here, we present evidence for Sox9 engagement in PTEC
repair after AKI. Lineage tracing demonstrates that the majority
of cells that restore kidney function come from a Sox9+ cell
type. Interestingly, Sox9 activity highlights remaining regions of
kidney damage after post-injury normalization of kidney function.
Genetic analysis indicates Sox9 activity is critical for a normal
repair process and developmental studies suggest Sox9 partic-
ipates in normal nephrogenesis. Thus, Sox9 action provides a
molecular link between formation and repair of the mammalian
nephron.1326 Cell Reports 12, 1325–1338, August 25, 2015 ª2015 The AuthorsRESULTS
Sox9 Activation on Kidney Injury
To identify cell-type-specific responses
after ischemia reperfusion injury (IRI) in
an acute kidney injury (AKI) model, we
performed translating ribosome affinity
purification (TRAP; Liu et al., 2014).
Examining the nephron tubular com-
partment 4 and 24 hr after renal IRI
highlighted a marked Sox9 upregulation
implicating Sox9-mediated transcrip-
tional regulation in the early response to
tubular injury (Figure 1A).
To examine the Sox9 response in more
detail, we compared the Sox9 expres-
sion profile from whole-kidney RNA-seq-uencing (RNA-seq) of adult malemice subjected to bilateral renal
IRI, an AKI model compatible with survival for at least 1 year
post-IRI, to kidneys from sham surgery control animals (Fig-
ure 1B). In this, model, a rise of serum creatinine levels (peaking
48–72 hr post-IRI) and restoration of basal creatinine levels 14–
28 days post-IRI provide an indirect physiological measure of
renal injury and repair (Figure 1B). Injury is associated with a
dramatic elevation of Lcn2 (Mishra et al., 2003) and Havcr1 (Ichi-
mura et al., 1998, 2008) (Figure 1B), two biomarkers currently
being assessed for clinical diagnosis of renal injury and repair
(Bonventre and Yang, 2010; Haase-Fielitz et al., 2014). Upregu-
lation of Sox9 preceded activation of Lcn2 and Havcr1 consis-
tent with Sox9 engagement in the earliest phase of the injury
response (Figure 1B). As with Havcr1 and Lcn2, Sox9 levels
peaked around 24–48 hr post-injury (a 20-fold elevation in
Sox9 levels in IRI versus sham surgery controls) paralleling the
rise in serum creatinine. However, whereas creatinine levels
were restored to baseline, Sox9, Havcr1, and Lcn2 expression
remained elevated 28 days post-IRI indicative of an ongoing
injury/repair response that may reflect an early stage in the AKI
to CKD progression observed in the clinic (Figure 1B). The
RNA-seq-based findings were independently corroborated by
quantitative Fluidigm real-time PCR analysis on kidney samples
(Figure 1C). Further, analysis of a unilateral ureteral obstruction
(UUO) injury model highlighted a similar upregulation of Sox9,
and the other injury-associated markers (Figure 1C). Thus, upre-
gulation of Sox9 is a general, early, and sustained transcriptional
response to distinct initiators of kidney injury (Figure 1 C).
To determine which cells express SOX9 in the normal and
injured kidney, we performed a detailed immunofluorescent
analysis on kidney sections comparing SOX9 specific antibodies
to a variety of antibody identifiers of key cell types in the mouse
kidney. In the uninjured adult kidney, rare individual SOX9+ cells
were present in PTECs as visualized by co-labeling with Lotus
tetragonolobus lectin (LTL) (0.05% of LTL+ PTECs; Figure 1D).
In addition, small clusters of cells were present in the calbin-
dinD-28k positive (CALB1+) distal tubule (DT) segment (4.1%
of CALB1+ DT; Figure 1E). No SOX9+ cells were detected
in the sodium potassium 2-chloride co-transporter positive
(NKCC2/SLC12A1+) thick ascending limb of the loop of Henle
or in the Aquaporin2+ collecting duct epithelium, the transit sys-
tem for urine emerging from the nephron.
A marked increase in SOX9+ cells was evident in PTECs 48 hr
post-AKI (Figures 2A–C0). By this time, 10.6% ± 0.6% of LTL+
PTECs were SOX9+ (Figure 2C), and the majority of SOX9+ cells
were restricted to the PTEC (Figure 2C0; 92% ± 0.6% of SOX9+
cells co-labeled as LTL+; p < 0.001). A comparative analysis
with de novo activation of the kidney injury response target
HAVCR1 demonstrated SOX9+ cells comprised a subset of the
HAVCR1+ population (Figures 2D–2F; 89% ± 6% of SOX9+ cells
were HAVCR1+; p < 0.001).
In the normal adult kidney, PTECs are largely quiescent; injury
is known to invoke a marked proliferative response within the
HAVCR1 population 48 hr post-IRI (Witzgall et al., 1994) (Figures
S1A and S1B). Ki67 labeling within injured PTECs indicates
that a large fraction (40%) of SOX9+ cells were actively prolifer-
ating at this time (Figures 2G–2I). Similarly, in a UUO-induced AKI
model, 10 days after obstruction, a significant increase in SOX9+
cells occurred in a subset of HAVCR1-expressing population
(98.4% ± 0.5% of SOX9+ were HAVCR1+, Figures S1C–S1E)
with nearly half of the proliferating PTECs (LTL+Ki67+) expressing
SOX9 (Figures S1F–S1H; LTL+Ki67+SOX9+; 49% ± 0.6% cells).
Similar to IRI-induced SOX9 activation, the vast majority of
SOX9+ was observed in nuclei of PTECs (Figures S1I; 97.4% ±
0.05% of SOX9% within the LTL+ tubules) of which approxi-
mately 16% were actively proliferating at this time (Figure S1J).
Thus, SOX9 demarcates a subset of proliferating, HAVCR1+
PTECs in the setting of ischemic and obstructive AKI.
Transcriptional analysis in our severe AKI recovery model indi-
cated that Sox9 andHavcr1 levels remain elevated 28 days post-
IRI, 2 weeks after serum creatinine levels normalized (Figure 1B).
Interestingly, we observed a population of SOX9+/HAVCR1+ co-
labeled cells at this time (Figures 3A and 3D) with a higher
concordance than the overlap 48 hr post-IRI (97% ± 0.5% of
SOX9+ cells were HACVR1+; p < 0.001 at 28 days). Labeling
was predominantly observed in dilated proximal tubules mosaicCellfor LTLhigh/SOX9– PTECs and zones of LTLlow/SOX9+ cells
without evident epithelial polarity typical of normal PTEC: an api-
cal, LTL-enriched brush border (Figures 3B and 3E; 91% ± 1.9%
of SOX9+ cells were LTL+). As at early stages, tubules retaining a
reparative signature also demonstrated a high percentage of
Ki67+ proliferative cells predominantly within the SOX9+ cell frac-
tion of the proximal tubule (Figures 3C and 3F; 26% of SOX9+
cells were Ki67+). Together these data suggest that in tubules
failing to resolve repair, SOX9+ cells continue to mount a prolifer-
ative repair response that may have relevance to the enhanced
likelihood of progression to CKD after AKI (see Discussion).
Sox9+ Cells Are Major Contributors to Renal Tubule
Repair
To determine whether Sox9+ cells actively contribute to renal
repair, we performed in vivo genetic fate mapping of Sox9+ cells
early on renal IRI. Adult mice expressing a tamoxifen (TM)-
dependent form of Cre recombinase under control of the Sox9
gene (Sox9IRES-CreERT2/+; Furuyama et al., 2011) were crossed
to a CRE-dependent td-Tomato reporter strain (R26RtdTomato;
hereafter referred to as R26RtdT; (Madisen et al., 2010; Soriano,
1999). To confirm the reporter faithfully recapitulated, Sox9
expression in the kidneys after IRI, we examined SOX9+
and tdT+ co-labeling 48 hr after IRI injury and TM injection in
Sox9IRES-CreERT2/+; R26RtdT/+ mice. As expected, we observed
a marked increase in SOX9+ cells on IRI relative to sham surgery
controls, and after injury, a subset of SOX9+ cells displayed tdT
fluorescence (tdT+) on TM-mediated activation of the reporter;
no reporter activity was observed on vehicle (corn oil) injection
or in non-injected IRI controls (Figures 4A and 4B; data not
shown). We did not find any evidence of ‘‘leaky’’ reporter in the
kidneys. Furthermore, RNA-seq-based profiling of the tdT+ cells
in the kidney of sham animals confirmed 5-fold enrichment for
Sox9 along with distal convoluted tubular markers, compared
to the unlabeled population consistent with the immunofluores-
cence data and reporter activation studies (data not shown).
Next, we subjected Sox9IRES-CreERT2/+:R26R tdT/+ adult male
mice to sham or renal IRI surgeries to obtain a fate map of early
expressing Sox9+ cells over a period of 4 weeks following injury.
Initially, we administered three doses of tamoxifen over a 4-day
period post-IRI (2 mg/animal/injection: 0, 48, and 96 hr post-
injury) and examined kidneys 28 days after injury (Figures S2A–
S2C).
In sham surgery control animals, rare scattered tdT+ cells were
restricted to LTL+, Aquaporin-1+ PTECs (Figures S2D and S2F),
while clusters of tdT+ cells were identified in CALB1+ distal tubule
segments (DT, Figure S2H) consistent with earlier SOX9 analysis
in the uninjured adult kidney. No tdT+ cells were observed in
other tubular compartments of the nephron including NKCC2+
cells of the thick ascending limb (TAL) of the loop of Henle (Fig-
ure S2J) or the aquaporin-2+ collecting duct epithelium (CD, Fig-
ure S2L). In marked contrast, we observed extensive tdT labeling
of the kidney after IRI (Figure S2C). The proximal tubule epithe-
lium (LTL+; Aquaporin1+) was lined by tdT+ cells (Figures S2E
and S2G) and significant TdT+ cells were detected in the loop
of Henle (NKCC2; Figures S2J and S2K) and the CD (Aqua-
porin-2+; Figures S2L and S2M); an enhanced tdT contribution
was also observed in the DT (CALB1+; Figures S2H and S2I).Reports 12, 1325–1338, August 25, 2015 ª2015 The Authors 1327
Figure 2. SOX9 Is Upregulated in the Injured, Proliferating Proximal Tubular Epithelial Cells 48 hr after Injury
(A and B) Immunoanalysis for SOX9 and LTL in kidneys 48 hr after sham (A) or renal IRI (B) surgery. Arrows highlight SOX9+ cells.
(C and C0) Quantification of the percentage of LTL+ proximal tubular cells expressing SOX9, and the percentage of SOX9+ cells in LTL+ proximal tubules (C0), 48 hr
post-injury.
(D and E) Immunoanalysis for SOX9 and HAVCR1 in kidneys 48 hr after sham (D) or renal IRI (E).
(F) Quantification of the percentage of SOX9+ cells in HAVCR1+ injured tubules 48 hr post-injury.
(legend continued on next page)
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Thus, IRI triggers a response that results in Sox9+ cells contrib-
uting extensively to repair of the proximal tubule. Further, the
great sensitivity of the CRE-system detects Sox9 activation at
levels not observed by direct antibody detection of Sox9 in other
kidney epithelium. Thus, Sox9 activation may be a broad, non-
vascular epithelial response to stress sensing and damage
where the degree of activation is linked to the severity of injury.
To obtain a better sense of the relationship between the
earliest SOX9 activity and repair outcome, we performed a sin-
gle, low-dose (1 mg/animal) TM administration immediately after
IRI (Figure S3A). A 4-fold increase was observed in tdT+ cells
within 48 hr and a 20-fold increase by 28 days post-IRI (Figures
4C–4F). The marked increase between 2 and 28 days follows the
onset of post-injury cell replication (Figures 4E and 4F). Prolifer-
ation of tdT+ cells at 48 hr was confirmed by incorporation of EdU
into nuclei undergoing DNA replication (Figures S3G and S3H).
Examination of tdT overlap with cell-type-specific markers
showed that by 48 hr post-injury the fraction of tdT+ cells was
markedly increased in LTL+ (Figures S3B, S3C, and S3E), Mega-
lin+, and ATP1A1+ PTECs (Figures 4G, 4H, 4J, and 4K) relative
to sham controls. This population of tdT+ PTECs expanded
further from 2 to 28 days post-IRI (Figures S3D and S3F; Figures
4I and 4L). Consistent with defective PT action, PTECs exhibited
a loss of the normal basolateral membrane restriction of ATP1A1
(a critical membrane NaKATPase transporter) in tdT+ cells 48 hr
post-IRI; however, polarity was restored in tdT+ cells 28 days
post-injury (Figures 4J–4N). A normalization of apical cell polarity
was also observed in apical megalin distribution (Figures 4G–4I).
Together, these data indicate that Sox9+ descendant cells pro-
liferate and regenerate a functional proximal tubular epithelium
after ischemic AKI.
Renal Repair by Resident SOX9+ Cells and De Novo
Activation of SOX9 in PTECs after IRI
To determine whether rare, resident Sox9+ PTECs were respon-
sible for the observed repair response, a multiday identical TM
regimen was used to maximize pre-surgery labeling of the pre-
existing Sox9 population of both sham and animals that were
subjected to renal IRI (2 mg/animal, three injections on 3 alter-
nating days). After 2 weeks of washout to remove any TM, ani-
mals were subjected to sham or IRI surgery (Figure S4A). As
expected, when the sham surgery procedure group was exam-
ined 28 days post-surgery, the vast majority of tdT+/Megalin+
PTECs were present as single cells in the uninjured cortices (Fig-
ures S4B and S4E; 94.8% ± 0.7%). The remainder consisted of
contiguous two (2% ± 0.08%) or three cell clusters (0.2% ±
0.02%), and non-contiguous two cell groupings (3% ± 0.5%).
None of the uninjured animals displayed more than three contig-
uous PTECs. In contrast, 4 weeks post-IRI, the proportion of
single, tdT+/Megalin+ cells was significantly reduced (12% ±
0.7%, p < 0.05), while a substantial fraction (13.5%) comprised
larger clusters with greater than ten contiguous cells (Figures
S4C–S4E).(G and H) Immunoanalysis for SOX9 and Ki67 in kidneys 48 hr after sham (G) or
(I) Quantification of percentage of SOX9+ cells coexpressing Ki67 after injury.
White arrows (E and H) point to the SOX9-expressing cells. Data shown in (C) an
DAPI demarcates nuclei. Scale bar, 100 mm. See also Figure S1.
CellTogether, these data suggest a limited expansion by resident
Sox9+ cells in the absence of injury over the 6-week course of
the experiment but a marked expansion after IRI consistent with
replication and repair by pre-existing Sox9 cells. However, the
overall extent of contribution of Sox9-descendant tdT+ cells to
the LTL+ proximal tubules was markedly reduced (Figure S4F,
5.6% ± 1.0%) compared with the contribution after TM labeling
of the Sox9+ pool immediately after IRI (Figure S4F, 75.1% ±
2.2%, p < 0.001) suggesting an extensive contribution from
PTECs that initiated de novo Sox9 activation on injury. Consistent
with this view, when all pre-existing Sox9+ cells were tdT-labeled
by a multi-day TM injection protocol (four consecutive injections
of 3 mg/animal) (Figure S4G), the vast majority of LTL+Sox9+
cells were tdT- 48 hr post-IRI (90.5% ± 2.2%), thereby suggest-
ing do novo activation of SOX9, in striking contrast to the
LTL+SOX9+tdT+ population (9.5% ± 3.1%), the resident SOX9+
PTECs (Figures S4H and S4I). These data demonstrate that PT
repair is realized predominantly by PTECs that undergo de novo
activation of Sox9 after AKI rather than an expansion of a pre-ex-
isting, intra-tubular resident Sox9+ PTEC population.
Sox9 Is Required for Normal Proximal Tubular Repair
after Ischemic AKI
Next, we sought to examine whether Sox9 activity is required
for PTEC repair after IRI. To this end, we made use of an
Slc34a1CreERT2/+ strain (Kusaba et al., 2014) to drive robust
TM-dependent CRE activity within S1 and S2 segments of the
PT. Though these cortical PT segments were less severely
affected than the S3 outer medullary segment after IRI (Bon-
ventre and Yang, 2011), a substantial contribution of tdT+
descendants ofSox9+ cells was observed in both S1 and S2 seg-
ments. Injection of four doses of TM (3 mg/mouse/injection) on
alternate days gave widespread reporter activation in 98.8% of
cells within the cortical LTL+ PT (Figures S5A–S5D). Analysis of
SOX9+ cells post-IRI demonstrated an expected overlap with
the Slc34a1CreERT2/+ labeled tdT+ PTECs (Figure S5E).
The injury-repair process was compared in adult kidneys of
Slc34a1CreERT2/+:Sox9fl/+ mice retaining a single active Sox9
allele in the S1 and S2 PT segment post-TM injection with that
of Slc34a1CreERT2/+ ; Sox9fl/fl mice where all Sox9 activity was
removed from S1 and S2 segments, verified by SOX9 immuno-
staining (Figure 5A; Figures S5F and S5G). Whereas creatinine
levels approached baseline (0.2 ± 0.04 mg/dl, Figure 5B)
5 days post-IRI in control mice retaining Sox9 activity in S1/S2
segments (Slc34a1CreERT2/+:Sox9fl/+), S1-S2-specific Sox9-defi-
cient mice (Slc34a1CreERT2/+;Sox9fl/fl) displayed significantly
elevated serum creatinine levels (0.56 ± 0.28mg/dl, p < 0.01, Fig-
ure 5B). However, by 28 days post-IRI, serum creatinine levels
were normalized in both groups (Figure 5B). Thus, loss of
SOX9 appears to slow but not prevent physiological renal repair
by this functional metric.
A blinded histological scoring of tubular epithelial injury in the
cortical S1 and S2 segments post-IRI revealed an enhancedrenal IRI (H).
d (F) are represented as mean ± SEM (*p < 0.05, **p < 0.01, n = 3 mice/group).
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Figure 3. Persistent Regional SOX9 Activity in Proximal Epithelial Tubules Displaying Ongoing Proliferative Repair Responses 28 Days
Post-IRI
(A) Immunoanalysis for SOX9 and HAVCR1 28 days post-IRI.
(B) Immunoanalysis for SOX9 and LTL 28 days post-IRI.
(C) Immunoanalysis for SOX9 and Ki67 28 days post-IRI. White arrows highlight SOX9+ cells.
(D) Quantification of percentage of SOX9+ cells in HAVCR1+ tubules 28 days post-IRI.
(E) Quantification of percentage of SOX9+ cells in LTL+ proximal tubules 28 days post-IRI.
(F) Quantification of percentage of SOX9+ and Ki67+ cells 28 days post-IRI
Data shown in (D) and (E) are represented as mean ± SEM (**p < 0.01, n = 3 mice/group). DAPI demarcates nuclei. Scale bar, 100 mm.initial injury (5 days) andmore dramatic tubular epithelial damage
response remaining 28 days post-IRI in the cortical S1 and S2
segments of Sox9-deficient mice (Figures 5C–5J); HAVCR1 im-1330 Cell Reports 12, 1325–1338, August 25, 2015 ª2015 The Authomunostaining analysis provided additional evidence for com-
prised repair in Sox9-deficient PTECs (Figures S5H and S5I).
When assayed by qPCR for a series of fibrotic indicators, thers
Figure 4. Proliferation and Repair of Prox-
imal Tubule Epithelium by SOX9+ Cells Pre-
sent Early on IRI
(A and B) Immunoanalysis for SOX9+ cells dem-
onstrates co-localization with SOX9-CREERT2-
activated tdTomato fluorescence (tdT+) in sham
surgery (A) and IRI (B) kidneys 48 hr post-TM in-
jection and surgery. Arrowheads highlight SOX9+/
tdTomato+ co-labeled cells.
(C–E) Representative images of tdT+ cells in whole
scanned kidneys harvested from mice that un-
derwent sham surgery (C), or IRI: 48 hr post-IRI (D),
28 days (E) post-IRI. Scale bar, 1,000 mm.
(F) Fluorescence-activated cell sorting (FACS)
quantification of tdT+ cells at baseline (sham ani-
mals), 48 hr, and 28 days post-IRI (sham, n = 3; IRI:
48 hr and 28 days, n = 4 mice/group).
(G–L) Immunoanalysis for megalin (G–I) and
ATP1A1 (NaKATPase; J–L) in sham surgery (G and
J), and IRI kidneys: 48 hr (H and K) and 28 days
(I and L) post-IRI.
(M) Quantification of the percentage of tdT+ cells
with normal or reduced and/or mislocalized
ATP1A1 (NaKATPase, normally polarized to ba-
solateral membrane surfaces) 48 hr post-IRI.
(N) Quantification of the percentage of tdT+ Sox9-
descendent cells normal and reduced and/or
mislocalized ATP1A1 28 days post-IRI.
Data in (M) and (N) are represented as mean ±
SEM (**p < 0.01, n = 3 mice/group). DAPI de-
marcates nuclei. Scale bar, 100 mm. See also
Figures S2–S4.cortices of S1-S2-specific Sox9-deficient mice showed a mark-
edly enhanced signature of renal fibrosis (Figures 5K–5N). Thus,
Sox9activity is requiredwithinPTECs for anormal repair process.
Activation of the Wnt-b-catenin pathway has recently been
linked to PTEC repair in ischemic AKI (Rinkevich et al., 2014).
To examine the relationship between canonical Wnt signaling
and Sox9-driven tubular epithelial repair responses, we sub-
jected TCF/Lef:H2B-GFP mice, a Wnt/b-catenin signaling re-
porter mouse strain (Ferrer-Vaquer et al., 2010) to sham or
renal IRI surgery. In the sham kidneys, 16.2% ± 2.3% of the
megalin+ PTECs displayed a GFPlow (GFPlow+) and 6.1% ±
2.3% a GFPhigh signal (GFPhigh+) (Figures S6A, S6C, and S6E),
a much larger fraction than the SOX9+ PTECs (0.05% of LTL+
PTECs). No SOX9+ cell co-localized with the GFPlow+ or GFPhigh+
cells in uninjured kidneys. Forty-eight hours post-IRI, a signifi-
cant increase was observed in both GFPlow (28.2% ± 4.2%)
and GFPhigh (28% ± 3.2%) populations of megalin+ PTECs
consistent with broad canonical Wnt/b-catenin pathway sig-
naling in PTECs after IRI (Figures S6B, S6D, and S6E). ThoughCell Reports 12, 1325–1338,a substantial proportion of SOX9+LTL+
cells co-localized with the GFP reporter
(26.4% ± 4.5%; Figures S6D, S6D0, S6F,
and S6G), the overlap of SOX9+ and
GFP+ cells was not significantly higher
than that expected by chance at this
time point (binomial p value = 0.9). Thus,
the data suggest that the SOX9+ cellsconstitute a distinct population with no significant enrichment
for engagement of the Wnt/ b-catenin pathway in its epithelial
reparative response 48 hr after ischemic AKI.
Sox9 Is Required for Normal Development of Proximal
Tubule Regions
To determine whether Sox9 combines a role in PTEC repair with
development of the PT, we examined SOX9 in the developing
mouse kidney. In the embryonic kidney 17.5 days post-fertiliza-
tion (e17.5), SOX9 was present in both the tips of the branching
ureteric tree and within distal regions of the S-shaped nephron
precursors (Figures S7A–S7C). By post-natal stage 4 (P4),
branching ceases and a final wave of nephrogenesis takes place
so that SOX9 was only detected in the developing nephron pop-
ulation (Figures S7D and S7E).
To fate map Sox9+ cell descendants during kidney develop-
ment, tamoxifen was injected into pregnant Sox9IRES-CreERT2/+:
R26R tdT/+ dams (single 2-mg dose) at e16.5 and tDT+/SOX9+
cells identified at e17.5 (Figure 6A). As expected, we observedAugust 25, 2015 ª2015 The Authors 1331
Figure 5. Tamoxifen-CRE-Dependent Sox9
Removal from S1 and S2 Proximal Tubule
Segments Impairs Renal Recovery Post-IRI
(A) Experimental outline of SOX9 removal before
IRI. Control (Slc34a1CreERT2/+:Sox9fl/+) and exper-
imental groups (Slc34a1CreERT2/+:Sox9fl/fl) were
administered tamoxifen pre-IRI (3 mg for four
doses, alternate days, i.p.), and subjected to IRI
1 week after the final TM injection.
(B) Serum creatinine measurements 5 and 28 days
post-IRI (*p < 0.05, Slc34a1CreERT2/+:Sox9fl/fl
versus Slc34a1CreERT2/+:Sox9fl/+ ; NS, non-signifi-
cant; n = 6 animals/group).
(C and D) Representative images of H&E-stained
cortical kidney sections. Asterisks indicate casts in
renal tubules and arrowheads highlight denuded
regions of epithelia.
(E) Quantitative scores of acute tubular injury
5 days post-IRI (*p < 0.05, Slc34a1CreERT2/+:
Sox9fl/fl versus Slc34a1CreERT2/+:Sox9fl/+; n = 5
animals/group).
(F and G) Representative images of H&E-stained
whole kidney sections 28 days post-sham (F) or IRI
(G) surgery.
(H and I) Representative images of H&E-stained
cortical kidney sections. Asterisks indicate tubules
retaining casts, and arrowheads highlight atro-
phied, dilated tubules.
(J) Quantitative scores of tubular injury 28 days
post-IRI (*p < 0.05, Slc34a1CreERT2/+:Sox9fl/fl
versus Slc34a1CreERT2/+:Sox9fl/+ ; n = 5 animals/
group).
(K–N) qPCR analysis of increased fibrosis in the
kidney cortices after Sox9 removal. Fibrosis was
assessed comparing genes associated with renal
fibrosis, Fn1 (K), Col1a1 (L), Col3a1 (M), and Acta2
(N) between Slc34a1CreERT2/+:Sox9fl/fl versus
Slc34a1CreERT2/+:Sox9fl/+ mice 28 days after injury
(*p < 0.05; n = 3 mice/group).
Data in (B), (E), and (J) are represented as mean ±
SEM. See also Figure S5. Scale bar, 200 mm. See
also Figures S5 and S6.an overlap of tDT+ cells in the ureteric tips with some additional
extension of tDT+ cells into adjacent stalk regions indicative of
commitment of a subset of cells within the Sox9+ tip progenitor
pool. In the developing nephron, labeling was observed in distal
components of the S-shaped body to the nephron junction with
theureteric epithelium (Figures6B–6E).Whenchased for 6weeks
into the adult kidney, tdT+ cells localized to Aquaporin-2+ collect-
ing duct epitheliumextending into the renal pelvis (Figure 6F), and
most segments of the nephron but not the glomerular region (Fig-
ures 6G–6I). Extensive nephron labeling was also evident from
imaging intact micro-dissected nephrons (Figure S6G). These
data indicate that descendants of a Sox9+ cell contribute to
most non-vascular epithelium within the normal kidney.
These results raise the possibility that Sox9may play a normal
role in nephron development in addition to nephron repair. Sox9
and Sox8 have been shown to regulate branching growth of the
ureteric network where the two genes are co-expressed (Regi-1332 Cell Reports 12, 1325–1338, August 25, 2015 ª2015 The Authonensi et al., 2011). The nephron primordium only expresses
Sox9, consequently Pax2Cre-driven genetic inactivation in a
Sox8/9 conditional mutant model removes Sox9 activity in the
nephron compartment in addition to removing Sox8 and Sox9
activity were each gene is co-expressed and co-active at ureteric
branch tips (Reginensi et al., 2011). Interestingly, kidneys from
mutantmice showed an absence of Slc5a+ and Slc5a2+ proximal
tubule (Figures 7E–7H) and Slc12a3+ distal tubule (Figures 7I and
7J) segments, while the Slc12a1+ thick ascending limb of the
loop of Henle was less severely affected (Figures 7K and 7L).
Together, the findings are consistent with Sox9 playing a role in
normal nephron development and renal repair.
DISCUSSION
We have identified Sox9 activation as a central component of the
early damage and repair response of injured renal tubule cells.rs
Figure 6. Fate Mapping of Sox9+ Cell Descendants Shows Extensive Contribution to the Ureteric and Nephron Epithelia
(A) Experimental outline of fate mapping of theSox9+ population inSox9IRES-CreERT2/+: R26R tdT/+ embryos. A single tamoxifen (2mg i.p.) dose was injected at 16.5
dpc. Kidneys were harvested at 17.5 dpc and at 6 weeks postnatally.
(B) Immunoanalysis for tdT and cytokeratin (green, ureteric epithelium). Representative images of whole kidneys scanned at E17.5. Scale bar, 100 mm.
(C) Immunoanalysis of SOX9+ and tDT+ cells in E17.5 kidneys.
(D and E) Immunoanalysis for cytokeratin (D, ureteric epithelium) and laminin, (E, broad basement membrane marker) and tdT in E17.5 kidney.
(legend continued on next page)
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SOX9+ cells re-enter mitosis and contribute extensively to resto-
ration of the proximal tubule. Activation of Sox9 is also observed
in other non-vascular tubular components less susceptible to IRI
using sensitive recombination-mediated reporters suggesting
that Sox9 may be targeted by a broad organ wide stress
response with maximal, immunodetectable levels in the most
metabolically active and stress-sensitive cells of the proximal
tubule. Analysis of a UUO kidney injury model suggests that acti-
vation of Sox9 is a general response to tubular injury.
Genetic studies focused on S1 and S2 segments of the prox-
imal tubule indicate that SOX9 is important in the kidney repair
process; SOX9 removal from these cells delayed the normaliza-
tion of kidney function and increased the residual kidney damage
signature. Interestingly, several weeks after restoration of kidney
function, foci of undifferentiated SOX9+ cells remained within the
proximal tubule. Co-expression of the injury reporter HAVCR1+,
and the absence of molecular indicators of normal PT cell func-
tion and polarity within this population, suggests that ongoing
SOX9 activity highlights tubular domains where epithelial func-
tion has not been restored, and an unresolved repair process re-
mains active. Clinical studies have highlighted a link between an
episode of AKI and the long-term progression to CKD (Chawla
et al., 2014; Coca et al., 2012). In this, the predominant focus
has been on pathological inflammatory responses in the kidney
seeded by initial fibrotic interstitial scarring within the pericyte
population that is first evident within a few days of AKI (Hum-
phreys et al., 2010; Kramann and Humphreys, 2014). Our find-
ings suggest that damaged kidney tubules locked into a repair
response that fails to terminate may represent an additional
mechanism triggering long-term maladaptive responses that ul-
timately lead to the loss of kidney function.
In development, SOX9 is present in the early developing
nephron and at the tips of the branching ureteric network where
the progenitors for the entire ureteric network reside (Reginensi
et al., 2011; Shakya et al., 2005). Our cell-fate studies demon-
strate that much of the non-vascular epitheliumwithin the kidney
is derived from a Sox9+ cell type. Thus, there is a close relation-
ship between the shared lineage of mature tubular epithelial cells
in the adult kidney from earlier SOX9+ renal progenitor popula-
tions, and kidney epithelia activating Sox9 on AKI.
The repair process does not broadly recapitulate develop-
mental stages of renal tubule specification and patterning
though there is some evidence for reactivation of specific regu-
latory components (Abbate et al., 1999; Imgrund et al., 1999; Lin-
doso et al., 2009; Terada et al., 2003; Villanueva et al., 2006). Our
analysis of Sox8 andSox9 compoundmutants that lackSox9 ac-
tivity within forming nephrons revealed a marked deficiency of
proximal and distal nephron segments consistent with a role of
Sox9 within the developmental program. We also observe very
rare SOX9+ cells (less than 0.1% of all mature cell types) that
co-express mature tubular markers in proximal tubule segments
of the uninjured adult kidney, and clusters of cells within distal tu-
bule segments. These findings suggest Sox9 may play a limited(F) Representative image of the tDT in whole scanned 6-week old kidneys harve
(G–J) Detailed analysis of tdT+ kidney labeled as in (F). Immunoanalysis for mega
Henle), CALB1 (I, calbindin-28 dk, distal convoluted tubule), and aquaporin2 (J, c
Representative images taken from n = 3 mice/group. Scale bar, 100 mm. See als
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types. Whether there are common molecular actions for Sox9 in
development and adult renal tubule function, maintenance, and
repair remains to be determined. Given the action of Sox9 (like
other Sox family members) as a pioneer transcription factor in
many cellular programming events, direct analysis of Sox9
DNA-target interactions, though technically challenging, is likely
to provide an important insight into the regulatorymechanisms at
play.
SOX9+ Cells and Cellular Mediators of Renal Tubule
Repair
Genetic lineage tracing studies have shown that intrinsic tubular
epithelial cells proliferate and repair the injured epithelium in the
mouse kidney (Berger and Moeller, 2014; Humphreys et al.,
2008; Kusaba et al., 2014). Our data lend additional support to
this model. SOX9 was clearly present with mature PT cells as
determined by co-labeling with LTL, aquaporin-1, megalin, and
ATP1A1. Further, pulse-chase cell-fate tracing of the earliest
cells activating Sox9 in response to IRI through a single TM injec-
tion at the time of IRI predominantly labeled intratubular epithelial
cells that expanded significantly to effect repair over the 28 day
post-injury study period.
Whether PT repair is directed by a specific cell type within the
epithelium or represents a broad response open to any PT cell
surviving injury and activating an appropriate repair pathway re-
mains contentious. Studies with an NFATc1-CRE mouse strain
have linked an NFATc1+ cell type to tubular repair (Langworthy
et al., 2009). Others have invoked a rare CD133+CD24+ cell re-
taining an uncommitted early nephron potential as the cellular
mediator of human and mouse PT repair (Angelotti et al., 2012;
Lazzeri et al., 2007). However rigorous cell-fate tracing, the
only definitive approach to relate cell type to specific injury is
clearly problematic for human kidney studies.
Strong evidence in favor of repair by mature cortical PTECs
comes from tracing descendants of Slc34a1+ cells in the S1
and S2 segments of the PT (Kusaba et al., 2014). Further, clonal
analysis comparing descendants of individual, randomly labeled
Slc34a1+ cells found no evidence for dramatically variable clone
size among the clonal populations supporting a model wherein
all cells have similar regenerative capability (Kusaba et al.,
2014). Similar conclusions have been drawn from a rhabdomyol-
ysis-induced AKI model were cell labeling is not restricted to the
PT compartment of the kidney (Rinkevich et al., 2014).
Though we observe rare SOX9+ PTECs in the uninjured adult
kidney, pre- and post-injury pulse-chase labeling and cell-fate
tracking of the descendants of SOX9+ cells suggest these cells
have a minor contribution overall to the repair process. As one
example, significant proliferative activity is first evident 48–72
post-IRI, but by 48 hr there is already a marked increase in
SOX9+ cells within damaged PT segments that cannot be ac-
counted for by expansion of a rare resident Sox9+ cell type.
The major contribution must come from de novo activation ofsted after labeling with single dose of tamoxifen (2 mg, i.p.) at E16.5.
lin (G, proximal tubular epithelium), NKCC2 (H, thick ascending limb of loop of
ollecting duct).
o Figure S7.
rs
Figure 7. Sox9 Removal from the Mouse Kidney Results in a Marked
Reduction of Nephron Components
(A–D) PAS staining of E18.5 kidneys from wild-type and Pax2:Cre;Sox9fl/fl;
Sox8/ mutant animals. Glomerulus (g), proximal tubule (p), distal tubule (d).
Scale bar, 200 mm.
(E–L) RNA in situ hybridization for Slc5a2 (E and F) and Slc5a1 (G and H) (so-
dium glucose linked transporter-2 and -1, respectively; proximal convoluted
CellSox9 in surviving differentiated PTECs. Importantly, this does
not rule out a role for a rare SOX9+ PTEC in renal tubule mainte-
nance under normal physiological conditions; additional studies
will be required to examine this population in more detail.
Recent experiments examining canonical Wnt-pathway re-
porters have suggested activation of canonical Wnt-signaling
accompanies PTEC repair (Rinkevich et al., 2014). In the unin-
jured adult kidney, we observe a substantial fraction of PTECs
have activated a canonical Wnt reporter (approximately 30%).
Given the nature of the reporter, which utilizes aGFP-tagged his-
tone as readout of pathway activation, we cannot determine
whether signaling reflects ongoing or historical signaling, and
if historical when relative to the time of analysis. However, it is
clear there is no significant overlap in Wnt-response in normal
PTECs and rare SOX9+ cell types. A significant overlap is
observed in cells displaying Wnt-reporter expression post-injury
and SOX9+ cells. The fraction of both cell types within the popu-
lation of PT cells increases post-injury, more dramatically for
SOX9 (SOX9+ cells and TCF/Lef1:H2B-eGFP+ cells increased
by 20- and 5-fold, respectively, 48 hr after injury) as a result of
broad, injury invoked de novo activation. However, there are
clearly many cells that are Sox9+ and Wnt reporter negative
(73.6% ± 2.4%) and Wnt reporter positive and Sox9– (92.1% ±
6.5%), and statistical analysis indicates there is no significant
co-association between the two cellular populations. Thus, there
is no clear-cut relationship between Wnt pathway induction and
Sox9 activity that can be discerned in the current analysis of
renal repair.
Sox9 Action in Tissue Specification, Homeostasis, and
Repair
In development, Sox9, like other Sox-family members, maintains
stem cell/progenitor states and promotes the differentiation of
mature cell types depending on the organ system, timing, and
tissue type (Kamachi and Kondoh, 2013; Sarkar and Hochedlin-
ger, 2013). Sox9 maintains the stem/progenitor cell state of hair
follicles (Nowak et al., 2008), multi-potent retinal progenitor cells
(Poche´ et al., 2008), neural stem cells (Cheung and Briscoe,
2003), and Sox9 is upregulated in mammary stem cells (Guo
et al., 2012). Sox9 also plays a pivotal role in the programming
of embryonic liver and pancreas progenitors (Kawaguchi,
2013), elaboration of all skeletal structures (Wright et al., 1995),
and gonadal sex determination (Kent et al., 1996), and Sox9 ac-
tivity marks pituitary progenitors of endocrine lineages (Rizzoti
et al., 2013).
Interestingly, SOX9+ cell types have been linked to epithelial-
based repair in the pancreas and liver after injury suggesting
possible parallels with the injury responses in the kidney. SOX9
is upregulated in the urothelium after varied insults including
exposure to carcinogen and hydrogen peroxide (Ling et al.,
2011). These studies have implicated epidermal growth factor re-
ceptor/extracellular signal-regulated kinases1/2 (EGFR/ERK1/2)
signaling in Sox9 induction. As ERK1/2 signaling is rapidlytubule specific markers), Slc12a3 (I and J) (thiazide-sensitive sodium chloride
cotransporter: distal convoluted tubule specificmarker), and Slc12a1 (K and L)
(sodium potassium 2 chloride cotransporter: thick ascending limb of loop of
Henle specific marker). Scale bar, 100 mm.
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activated after renal IRI (Kumar et al., 2009), this pathway is one
candidate for mediating Sox9 activation. Hypoxia-mediated in-
duction may represent another. In chondrocyte development,
hypoxia-inducible factor-1 alpha (Hif1a) directly binds to the
Sox9 promoter regulating Sox9 expression (Zhang et al., 2011).
Sox9 is also known to regulate its own expression in chondro-
cytes and Sertoli cells of the testis (Mead et al., 2013). Thus,
persistent Sox9 expression in unresolved repair could reflect
ongoing Sox9 induction by Sox9-independent regulatory pro-
cesses, or the absence of inhibitory factors that normally termi-
nate SOX9’s auto regulatory action on successful repair of PT
epithelium.
In vertebrates, the dedifferentiation of quiescent differentiated
cells into a replicating progenitor or progenitor-like cell state has
been linked to the repair of epithelial airways (Tata et al., 2013).
Here, there may be parallels here with the AKI model. On AKI,
a serious life-threatening event, the drive is to rapidly replace
up to 80% of PTECs to ensure the individual’s survival. The PT
is a complex, highly organized structure with distinct regional
foci of transporter and channel proteins mediating its essential
physiological actions. The rapid reprogramming by stress re-
sponses of surviving, quiescent differentiated cells to a prolifer-
ative state, while simultaneously preserving a cell’s positional
identity within the nephron to enable the reformation of appro-
priate, regionally restricted differentiated cell types, would be
an effective means to this end. Interestingly, clonal studies
of renal repair have highlighted the regionally restricted differen-
tiation capability of repairing cells consistent with this view
(Rinkevich et al., 2014).
In summary, our data provide evidence for Sox9 activation as
an early transcriptional response to renal injury. Further, Sox9
likely acts as a broad facilitator of epithelial repair. Sox9 co-op-
ted organ repair contrasts with stem-cell-based models of repair
identified in many organ systems. As such, a Sox9-directed
mechanism may represent an expedient, alternative repair pro-
cess designed to rapidly recruit any surviving mature cell type
post-injury into a transient reparative state.
EXPERIMENTAL PROCEDURES
See Supplemental Experimental Procedures for an extended and detailed
description of the materials and methods used.
Mice and Injury Models
Sox9IRES-CreERT2/+ (Furuyama et al., 2011), R26RtdTomato/tdTomato (JAX stock
number 007909), Slc34a1CreERT2/+ mice (Kusaba et al., 2014), TCF/Lef:H2B-
GFP mice (JAX stock number 013752), Sox9fl/fl (JAX stock number 013106),
and Pax2Cre:Sox8/9 double-knockout mutants mice were described previ-
ously (Reginensi et al., 2011). Renal ischemia reperfusion injury and unilateral
ureteral obstruction models followed published injury-modeling procedures
(Fabian et al., 2012). Adult (10–12 weeks, 25–28 g) male mice were employed
for all adult experimental analysis. Standard analysis used C57BL/6 inbred
strains. All surgical procedures, and all mouse handling and husbandry were
performed according to guidelines issued by the Institutional Animal Care
and Use Committees (IACUC) at each institution.
For lineage tracing in the embryonic kidney, noon on the day of vaginal plug
detection was considered embryonic day 0.5 (E0.5). For induction of CreERT2
protein, mice were injected with tamoxifen (Sigma, #T5648) dissolved in corn
oil (Sigma, #C8267) via an intra-peritoneal (i.p.) route. The dosing schedule,
frequency, and timing of the administration are documented in relation to
the experiment in the results section.1336 Cell Reports 12, 1325–1338, August 25, 2015 ª2015 The AuthoImmunofluorescence, Histology, In Situ Hybridization, Microscopy,
and Imaging
Kidneys were harvested and fixed by intra-cardiac perfusion with 4% para-
formaldehyde. Immunofluorescence was performed on 6-mm cryosections
using primary and secondary antibodies described in the Supplemental In-
formation. Images were acquired using either a confocal microscope (Carl
Zeiss 780 LSM), or slide scanner (Zeiss Axioscan.Z1). For conventional his-
tology, H&E or periodic acid-Schiff (PAS) staining was performed according
to the routine histology protocols on 5-mm-thick paraffin sections. Semiquan-
titative analysis of tubular morphology was performed in a blinded fashion
as described in the Supplemental Information. Images were acquired on a
slide scanner (Zeiss Axioscan.Z1) and upright Nikon Eclipse 90i microscope.
In situ hybridization and histology of embryonic kidneys is detailed in the
Supplemental Information.
Quantifying Transcript Levels in Kidney Cell Types
The use of RNA-seq and Fluidigm PCR to assess transcription in whole
kidneys or kidney subsets of kidney cells are described in the Supplemental
Information. This includes details on kidney digestion and FACS of cell
types.
Statistical Analysis
All values are reported as mean ± SEM. Statistical significance was calculated
by the unpaired t test for unpaired observations. All statistical analysis was
performed using GraphPad Prism v.4.03 (GraphPad Software). A binomial p
value significance test was used to examine association between SOX9 and
GFP expression. p values of 0.05 or less were considered significant. All t tests
used two-sided t test analysis.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at http://dx.doi.
org/10.1016/j.celrep.2015.07.034.
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